marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Kala Pharmaceuticals Income Statement 2011-2024 | KALA
Annual Income Statement Kala Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
19.4 M | 22.5 M | 1.59 M | 416 M | 213 M | 143 M | 103 M | - | - | - | - | - | - |
Shares |
2.43 M | 1.52 M | 1.32 M | 56 M | 34.2 M | 26.8 M | 6.9 M | - | - | - | - | - | - |
Historical Prices |
7.97 | 14.8 | 1.21 | 6.78 | 3.69 | 4.89 | 18.5 | - | - | - | - | - | - |
Net Income |
-42.2 M | -44.8 M | -143 M | -104 M | -94.3 M | -66.7 M | -42.2 M | -33.2 M | -16.7 M | - | - | - | - |
Revenue |
- | 3.89 M | 11.2 M | 6.36 M | 6.07 M | - | - | - | 45 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 3.19 M | 4.07 M | - | - | - | - | - | - | - | - |
Operating Income |
-39.7 M | -81.7 M | -130 M | -96.2 M | -88.2 M | -64.7 M | -39.9 M | -32.7 M | -15.9 M | - | - | - | - |
Interest Expense |
5.81 M | 7.27 M | 8.38 M | 8.59 M | 8.48 M | 3.31 M | 1.02 M | 767 K | 604 K | - | - | - | - |
EBITDA |
-39.4 M | -81.2 M | -129 M | -95.3 M | -87.4 M | -63.8 M | -39.6 M | -32.2 M | -15.6 M | - | - | - | - |
Operating Expenses |
39.7 M | 85.6 M | 141 M | 99.4 M | 92.3 M | 64.7 M | 39.9 M | - | - | - | - | - | - |
General and Administrative Expenses |
20.6 M | 65 M | 105 M | 81.1 M | 65 M | 35.4 M | 10.9 M | 7.64 M | 4.61 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Kala Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.63 M | 3.03 M | 2.81 M | 2.76 M | 2.55 M | 2.39 M | 2.07 M | 1.71 M | 1.5 M | 1.49 M | 1.49 M | 1.32 M | 1.31 M | 64.6 M | 61.7 M | 58.9 M | 56 M | 55.7 M | 40.8 M | 36.1 M | 34.2 M | 33.9 M | 33.9 M | 33.9 M | 24.6 M | 24.6 M | 24.5 M | 24.5 M | 18 M | 1.18 M | 1.18 M | 1.18 M | 1.18 M | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-8.95 M | -9.58 M | -11.8 M | - | -8.7 M | -10.4 M | -14.5 M | - | 29.1 M | -28.1 M | -32.9 M | - | -28.1 M | -36.5 M | -30.4 M | -31.1 M | -27.9 M | -23.3 M | -22 M | -22 M | -23.2 M | -23.8 M | -25.4 M | -25.2 M | -15.6 M | -14.6 M | -11.3 M | -11.3 M | -30.9 M | -20.7 M | -9.76 M | -8.4 M | -24.8 M | -15.1 M | -5.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | 420 K | 2.1 M | 1.37 M | - | 3.07 M | 3.05 M | 3.27 M | 2.24 M | 2.22 M | 833 K | 1.07 M | 1.18 M | 1.45 M | 2.06 M | 1.39 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 241 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-9.99 M | -9.6 M | -11.9 M | - | -8.76 M | -9.6 M | -11.7 M | - | -14.6 M | -26 M | -30.9 M | - | -26.1 M | -29 M | -28.3 M | - | -25.8 M | -21.3 M | -20.1 M | - | -21.6 M | -22.4 M | -24 M | - | -15.5 M | -14.5 M | -11.1 M | - | -9.53 M | -9.63 M | -9.57 M | - | -9.75 M | -9.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 1.46 M | - | -2.16 M | -119 K | 1.47 M | - | 1.45 M | 2.21 M | 2.04 M | - | 2.07 M | 2.09 M | 2.14 M | - | 2.16 M | 2.13 M | 2.13 M | - | 2.18 M | 2.06 M | 2.09 M | - | 432 K | 414 K | 367 K | - | 212 K | 208 K | 198 K | - | 186 K | 186 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -11.9 M | - | - | - | -11.6 M | - | -14.1 M | -25.7 M | -30.8 M | - | -25.3 M | -28.5 M | -28.1 M | - | -25.2 M | -20.8 M | -19.9 M | - | -21 M | -22 M | -23.9 M | - | -15.3 M | -14.3 M | -11.1 M | - | -9.32 M | -9.49 M | -9.5 M | - | -9.53 M | -9.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
9.99 M | 9.6 M | 11.9 M | - | 8.76 M | 9.6 M | 11.7 M | - | 15 M | 28.1 M | 32.3 M | - | 29.1 M | 32.1 M | 31.6 M | 31.2 M | 28.1 M | 22.1 M | 21.2 M | 21.4 M | 23 M | 24.5 M | 25.4 M | 23.6 M | 15.5 M | 14.5 M | 11.1 M | 11.1 M | 9.53 M | 9.63 M | 9.57 M | 8.2 M | 9.75 M | 9.65 M | 5.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.4 M | 4.32 M | 5.42 M | - | 4.95 M | 4.96 M | 6.03 M | - | 9.55 M | 22.7 M | 27 M | - | 25.3 M | 28 M | 27.7 M | - | 23.9 M | 15.3 M | 15.4 M | - | 15.3 M | 17 M | 18.2 M | - | 8.47 M | 7.15 M | 5.48 M | - | 2.52 M | 1.56 M | 1.53 M | - | 1.49 M | 3.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency